Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals
/PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV), a leading addiction treatment company, today announced that it has gained exclusive global rights to develop,...
United States Hong Kong Christian Heidbreder Alar Pharmaceuticals Inc Prnewswire Indivior Lead Asset
Source: prnewswire.com